In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 10, Issue 11, Pages 1309
Publisher
MDPI AG
Online
2021-10-28
DOI
10.3390/antibiotics10111309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections
- (2021) Katie A Parsels et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives
- (2021) Marco Terreni et al. MOLECULES
- In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii
- (2021) Jacinda C. Abdul-Mutakabbir et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia
- (2020) Mercedes Delgado-Valverde et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cefiderocol: A Siderophore Cephalosporin
- (2020) Rania M. El-Lababidi et al. ANNALS OF PHARMACOTHERAPY
- Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety
- (2020) Young Ran Lee et al. CLINICAL DRUG INVESTIGATION
- Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3
- (2020) Saquib Malik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients
- (2020) Marco Falcone et al. CLINICAL INFECTIOUS DISEASES
- Comparison of Agar Dilution to Broth Microdilution for Testing in vitro Activity of Cefiderocol against Gram-negative Bacilli
- (2020) Mariana Albano et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-negative Bacilli: A Comparison of Disk Diffusion to Broth Microdilution
- (2020) C. Paul Morris et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Determination of Colistin Resistance by Simple Disk Diffusion Test Using Modified Mueller-Hinton Agar
- (2020) Jean Damascene Uwizeyimana et al. Annals of Laboratory Medicine
- Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine
- (2020) Patrick S. Gellings et al. Pathogens
- Evaluation of the OXA-23 K-SeT® immunochromatographic assay for the rapid detection of OXA-23-like carbapenemase-producing Acinetobacter spp.
- (2019) Eleonora Riccobono et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
- (2019) George G. Zhanel et al. DRUGS
- Reproducibility of broth microdilution MICs for the novel Siderophore cephalosporin, Cefiderocol, determined using Iron-depleted cation-adjusted Mueller-Hinton broth
- (2019) Meredith A. Hackel et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
- (2019) Mansura S. Mulani et al. Frontiers in Microbiology
- The Mechanisms of Disease Caused by Acinetobacter baumannii
- (2019) Faye C. Morris et al. Frontiers in Microbiology
- Development of Neutropenic Murine Models of Iron Overload and Depletion To Study the Efficacy of Siderophore-Antibiotic Conjugates
- (2019) James M. Kidd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria
- (2019) Yoshinori Yamano CLINICAL INFECTIOUS DISEASES
- Accuracy and applicability of different phenotypic methods for carbapenemase detection in Enterobacteriaceae: a systematic review and meta-analysis
- (2019) Hong Zhong et al. Journal of Global Antimicrobial Resistance
- The continued value of disk diffusion for assessing antimicrobial susceptibility in clinical laboratories: report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working Group
- (2018) Romney M. Humphries et al. JOURNAL OF CLINICAL MICROBIOLOGY
- In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
- (2018) Krystyna M. Kazmierczak et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
- (2018) Shun-Chung Hsueh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Managing Acinetobacter baumannii infections
- (2018) José Garnacho-Montero et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
- (2017) J. Dobias et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
- (2017) Chang-Ro Lee et al. Frontiers in Cellular and Infection Microbiology
- Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia
- (2016) M.P. Freire et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
- (2016) Darren Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Acinetobacter baumannii: biology and drug resistance — role of carbapenemases
- (2015) Pawel Nowak et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Evolution of Carbapenem-Resistant Acinetobacter baumannii Revealed through Whole-Genome Sequencing and Comparative Genomic Analysis
- (2014) Henan Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Involvement of Fe Uptake Systems and AmpC β-Lactamase in Susceptibility to the Siderophore Monosulfactam BAL30072 in Pseudomonas aeruginosa
- (2013) Christian van Delden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Acinetobacter baumannii: evolution of a global pathogen
- (2013) Luísa C.S. Antunes et al. Pathogens and Disease
- Characterization of resistance mechanisms and genetic relatedness of carbapenem-resistant Acinetobacter baumannii isolated from blood, Italy
- (2012) Roberta Migliavacca et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Inaccuracy of the Disk Diffusion Method Compared with the Agar Dilution Method for Susceptibility Testing of Campylobacter spp.
- (2011) Mirva Lehtopolku et al. JOURNAL OF CLINICAL MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started